Despite an unpredictable year, market activity continues. Learn what has changed--and what hasn't--for life sciences companies targeting an IPO or IPO/SPAC.
This workshop is co-hosted with Deloitte and designed for C-Suite executives and accounting/finance leaders of pre-IPO companies.
Join our panel of subject matter specialists on Thursday, December 3, to discuss market trends and their impact on various paths to a public exit for life sciences companies.
We'll be discussing:
Norilyn Ingram
ningram@wsgr.comJennifer helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards.